Oncology Why precision biomarkers will change the future of breast ca... Blood-based biomarkers can provide an earlier, dynamic view of what is happening inside a patient, creating an opportunity to detect changes sooner.
Oncology Early diagnosis means little without timely treatment Early diagnosis only changes outcomes if it is followed by timely treatment.
Patients Sponsored Why rare kidney diseases must be part of the CKD conversatio... A look at the benefits of genetic testing in diagnosis of rare kidney diseases, from HealthLumen.
Oncology The role of advanced imaging in transforming early detection... The future of prostate cancer care lies in reimagining how we diagnose and monitor the disease.
Patients Exploring the role of pharmacy and self-care in the fight ag... Globally, the incidence of fatty liver disease is increasing at a concerning rate, yet, the solution could be simple.
R&D Commercialising IVDs – The complex path towards access to ea... Early diagnosis through the use of in vitro diagnostics (IVDs) plays a critical role in patient outcomes and in supporting the healthcare system as a whole.
News Merck charts course out of CDMO business with Lonza sale Merck KGaA has moved to streamline its focus with the sale of its contract development and manufacturing organisation (CDMO) business to Lonza.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.